Aberrant Type I Interferon Regulation in Autoimmunity: Opposite directions in MS and SLE, shaped by Evolution and Body Ecology

by Anthony T Reder, Xuan eFeng
Published 2013-09-01

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection

by Xuan Feng, Riyue Bao, Lei Li, Florian Deisenhammer, Barry G.W. Arnason, Anthony T. Reder
Published 2019-11-01

Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.

by Fredrika Koskimäki, Jacqueline Bernard, Jeong Yong, Nancy Arndt, Timothy Carroll, Seon-Kyu Lee, Anthony T Reder, Adil Javed
Published 2018-01-01

Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling

by Tiffany Tran, Pedro Paz, Sharlene Velichko, Jill Cifrese, Praveen Belur, Ken D. Yamaguchi, Karin Ku, Parham Mirshahpanah, Anthony T. Reder, Ed Croze
Published 2010-01-01

Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS.

by Douglas S Goodin, Jason Jones, David Li, Anthony Traboulsee, Anthony T Reder, Karola Beckmann, Andreas Konieczny, Volker Knappertz, 16-Year Long-Term Follow-up Study Investigators
Published 2011-01-01